Global Skin and Soft Tissue Infection Treatment Market Size, Share, Growth, Trends and Forecast 2016 - 2024
"The
Latest Research Report Skin and Soft Tissue Infection Treatment
Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast 2016 - 2024 provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
Skin and Soft Tissue
Infection Treatment Market: Overview
Skin and soft tissue infections
(SSTIs) are one of the most common infections present in inpatient as
well as outpatients. Skin and soft tissue infections (SSTIs) comprise
of various minor and major infections of skin, fascia, subcutaneous
tissue and muscle. These infections include such as impetigo,
folliculitis, furuncles, carbuncles, erysipelas, cellulitis,
necrotizing fasciitis and pyomyositis. These infections may be
associated with an underlying cause such as diabetes or systemic
immunosuppression.
Skin and soft tissue infections
(SSTIs) may be caused by any of the pathogenic microorganisms which
include Staphylococcus aureus, Streptococcus pyogene, gram-negative
bacilli, Pseudomonas aeruginosa, beta-hemolytic streptococci,
Enterococcus, streptococci, staphylococci, Peptostreptococcus,
Bacteroides, Clostridium and S. pyogenes. Methicillin-resistant
Staphylococcus aureus (MRSA) and streptococci are the most common
organisms causing skin and soft tissue infections (SSTIs).
Skin and Soft Tissue
Infection Treatment Market: Segmentation
The market for skin and soft
tissue infections treatment is analyzed based on the medications used
for its treatment which includes antibiotics and anti-fungal agents.
Traditionally, use of beta-lactam antibiotics has proved to be
beneficial against various skin and soft tissue infections. However,
with rising use of these traditional medications has led to
resistance of these bacteria against the beta-lactam antibiotics.
Moreover, new strains of
infectious bacteria urge the need for development of new therapies.
Consequently physicians have started using the third-generation
antibiotics such as cephalosporins, fluoroquinolones or
extended-spectrum agents such as amoxicillin and clavulanic acid. The
selection of an appropriate drug depends on the causative
microorganism. Besides medications, imaging tools and surgical
methods are also practiced for the treatment of skin and soft tissue
infections (SSTIs).
Skin and Soft Tissue
Infection Treatment Market: Key Trends
The rising incidence of
Methicillin-resistant Staphylococcus aureus (MRSA) infections has
resulted in the need for new therapies to combat the serious skin and
soft tissue infections. In addition, new product developments will
drive the skin and soft tissue infections treatment market. Recently,
in February 2014, Cubist Pharmaceuticals, Inc. announced that its
Marketing Authorization Application (MAA) for investigational
candidate tedizolid phosphate has been accepted by the European
Medicines Agency (EMA) for review. With a decision expected from the
European Commission (EC) during the first half of 2015, the company
seeks to market its new product for the treatment of skin and soft
tissue infections.
Prior to EMA, the U.S. FDA
accepted company’s New Drug Application (NDA) for review and the
company had also planned for submitting a New Drug Submission (NDS)
in Canada in 2014 for tedizolid intended for the treatment of skin
and soft tissue infections. Moreover, in December 2013, Durata
Therapeutics, Inc. announced the acceptance of its Marketing
Authorization Application (MAA) for dalbavancin, intended for the
treatment of skin and soft tissue infections, by the European
Medicines Agency (EMA) for review.
View
Report @
https://www.marketresearchreports.biz/reports/1357484/skin-and-soft-tissue-infection-market-research-reports
The Infectious Diseases Society
of America has recently released guidelines for the diagnosis and
management of skin and soft tissue infections (SSTIs). This practice
guideline is to guide the physicians in proper diagnosis and
efficient treatment of the skin and soft tissue infections and avoid
serious consequences. Based on geography, the skin and soft tissue
infections treatment market is analyzed into North America, Europe,
Asia-Pacific and Rest of the World.
Skin and Soft Tissue
Infection Treatment Market: Key Players
Some of the companies engaged
in the development of skin and soft tissue infection (SSTI)
treatment medications include Cubist Pharmaceuticals, Inc., Wockhardt
Limited, Atox Bio Inc., Durata Therapeutics, Inc., Basilea
Pharmaceutica AG, and Melinta Therapeutics Inc.
The report offers a
comprehensive evaluation of the market. It does so via in-depth
insights, understanding market evolution by tracking historical
developments, and analyzing the present scenario and future
projections based on optimistic and likely scenarios. Each research
report serves as a repository of analysis and information for every
facet of the market, including but not limited to: Regional markets,
technology developments, types, applications, and the competitive
landscape.
The study is a source of
reliable data on:
Key market segments and
sub-segments
Evolving market trends and
dynamics
Changing supply and demand
scenarios
Quantifying market
opportunities through market sizing and market forecasting
Tracking current
trends/opportunities/challenges
Competitive insights
Opportunity mapping in
terms of technological break throughs
The regional analysis
covers:
North America (U.S. and
Canada)
Latin America (Mexico,
Brazil, Peru, Chile, and others)
Western Europe (Germany,
U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands,
Luxembourg)
Eastern Europe (Poland,
Russia)
Asia Pacific (China, India,
Japan, ASEAN, Australia and New Zealand)
Middle East and Africa
(GCC, Southern Africa, North Africa)
Send
An Enquiry Request @
https://www.marketresearchreports.biz/sample/enquiry/1357484
TMR estimates the market size
of various sectors using a combination of available data on the
number and revenue of companies within each sub-sector and tiers of
companies. The basic components used to determine market size and
forecast for a specific product area are not only limited to
supply-side data, but are also related to demand, industry trends,
and the economic outlook. All the above data points are utilized to
generate a statistical model targeting the sector marketplace. More
than 300 TMR analysts across the world integrate these elements into
a framework to determine the subsector market size for a base year
and then forecast growth within each market.
TMR regularly interviews
technology and business professionals as an ongoing effort to track
the latest developments within each sector. These continuous surveys
are stratified by company size and industry segment and weighted to
reflect the global market place. All data are collected on an
ongoing effort through a structured questionnaire rolled over the web
or conducted via telephones. This provides the TMR team opportunities
to request for detailed question sets, complex skip patterns, and
real-time calculations, which assists respondents in answering
questions involving numbers and percentages. Respondents, who are
interviewed as experts, are screened and qualified based on certain
criteria in addition to their decision-making authority and the scope
of activity within their organizations.
Check Discount This Report
From Here @
https://www.marketresearchreports.biz/sample/checkdiscount/1357484
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment